Artia Global Partners Lp Top Holdings and 13F Report (2026) About Artia Global Partners LpInvestment ActivityArtia Global Partners Lp has $541.86 million in total holdings as of June 30, 2026.Artia Global Partners Lp owns shares of 48 different stocks, but just 18 companies or ETFs make up 80% of its holdings.Approximately 26.02% of the portfolio was purchased this quarter.About 20.19% of the portfolio was sold this quarter.This quarter, Artia Global Partners Lp has purchased 49 new stocks and bought additional shares in 11 stocks.Artia Global Partners Lp sold shares of 3 stocks and completely divested from 9 stocks this quarter.Largest Holdings ABIVAX SA $68,821,727Insmed $62,804,724Trevi Therapeutics $41,232,390BRIGHTSPRING HEALTH SVCS INC $36,077,548Revolution Medicines $34,719,839 Largest New Holdings this Quarter G01767105 - Alkermes $23,523,469 Holding78464A870 - SPDR S&P Biotech ETF $15,825,000 Holding40131M109 - Guardant Health $5,716,143 Holding00091E109 - Absci $5,382,906 HoldingK08588103 - ASCENDIS PHARMA A/S $4,731,613 Holding Largest Purchases this Quarter BRIGHTSPRING HEALTH SVCS INC 463,515 shares (about $32.33M)Alkermes 448,964 shares (about $23.52M)SPDR S&P Biotech ETF 100,000 shares (about $15.83M)Travere Therapeutics 268,333 shares (about $15.24M)Revolution Medicines 60,400 shares (about $11.31M) Largest Sales this Quarter Insmed 319,360 shares (about $34.05M)ABIVAX SA 84,300 shares (about $11.23M)ALUMIS INC 46,500 shares (about $1.31M) Sector Allocation Over TimeMap of 500 Largest Holdings ofArtia Global Partners Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorABIVAX SA$68,821,727$11,233,818 â–¼-14.0%516,44712.7%SPONSORED ADSINSMInsmed$62,804,724$34,050,163 â–¼-35.2%589,05211.6%HealthcareTRVITrevi Therapeutics$41,232,390$3,678,713 â–²9.8%2,210,8527.6%HealthcareBRIGHTSPRING HEALTH SVCS INC$36,077,548$32,325,536 â–²861.6%517,3156.7%COMRVMDRevolution Medicines$34,719,839$11,311,712 â–²48.3%185,3906.4%HealthcareARGXargenex$27,590,9520.0%29,7395.1%HealthcareALKSAlkermes$23,523,469$23,523,469 â–²New Holding448,9644.3%HealthcareTVTXTravere Therapeutics$19,260,465$15,243,998 â–²379.5%339,0333.6%HealthcareAZNCFAstraZeneca$18,654,057$568,860 â–²3.1%98,3763.4%HealthcareNAMSNewAmsterdam Pharma$17,078,3910.0%503,9363.2%HealthcareDIANTHUS THERAPEUTICS INC$15,888,2650.0%162,9902.9%COMXBISPDR S&P Biotech ETF$15,825,000$15,825,000 â–²New Holding100,0002.9%ETFDGXQuest Diagnostics$13,802,608$5,151,445 â–²59.5%65,1222.5%HealthcareIONSIonis Pharmaceuticals$11,447,5730.0%144,3762.1%HealthcareEYPTEyepoint Pharmaceuticals$10,969,5010.0%767,0982.0%HealthcareALUMIS INC$7,838,284$1,308,510 â–¼-14.3%278,5461.4%COMVKTXViking Therapeutics$7,050,3160.0%180,7311.3%HealthcareCELCCelcuity$6,205,640$4,576,079 â–²280.8%59,3161.1%HealthcareCYTKCytokinetics$6,022,933$4,634,336 â–²333.7%70,7001.1%HealthcareMRKMerck & Co., Inc.$6,000,9500.0%46,7001.1%HealthcareRAPPORT THERAPEUTICS INC$5,771,6280.0%138,5081.1%COMJNJJohnson & Johnson$5,739,7220.0%22,6001.1%HealthcareGHGuardant Health$5,716,143$5,716,143 â–²New Holding38,1001.1%HealthcareABSIAbsci$5,382,906$5,382,906 â–²New Holding464,4441.0%HealthcareSRRKScholar Rock$5,295,6750.0%96,2851.0%HealthcareSIONNA THERAPEUTICS INC$5,267,4070.0%119,7411.0%COMASCENDIS PHARMA A/S$4,731,613$4,731,613 â–²New Holding17,7400.9%ORD SHSROIVRoivant Sciences$4,593,6220.0%129,8000.8%HealthcarePALISADE BIO INC$4,164,0470.0%1,992,3670.8%COMEWTXEdgewise Therapeutics$4,014,244$1,352,979 â–²50.8%98,8000.7%HealthcareBIIBBiogen$3,983,4980.0%18,4370.7%HealthcareXENEXenon Pharmaceuticals$3,923,4000.0%65,0000.7%HealthcareBLTEBelite Bio$3,847,9310.0%24,9890.7%HealthcareMLYSMineralys Therapeutics$3,717,8440.0%137,8000.7%HealthcarePROKIDNEY CORP$3,686,1560.0%1,806,9390.7%SHS CL AELVNEnliven Therapeutics$3,659,075$2,598,400 â–²245.0%72,1000.7%HealthcareORUKA THERAPEUTICS INC$3,178,678$3,178,678 â–²New Holding33,4000.6%COMPTGXProtagonist Therapeutics$2,813,334$2,452 â–²0.1%22,9510.5%HealthcareUTHRUnited Therapeutics$2,709,1500.0%5,0000.5%HealthcareBRIGHT MINDS BIOSCIENCES INC$2,696,1710.0%38,4070.5%COM NEWKINIKSA PHARMACEUTICALS INTL$1,867,3400.0%29,2000.3%ORD SHS CL ACMPXCompass Therapeutics$839,208$839,208 â–²New Holding383,2000.2%HealthcarePRAXIS PRECISION MEDICINES I$836,9750.0%2,5000.2%COM NEWKODKodiak Sciences$663,0600.0%17,0190.1%HealthcareTENAX THERAPEUTICS INC$612,2640.0%42,0800.1%COM NEWNUVLNuvalent$605,1500.0%4,9000.1%HealthcarePEPGPepGen$369,5830.0%205,3240.1%HealthcareSPYRE THERAPEUTICS INC$355,120$355,120 â–²New Holding4,0000.1%COM NEWLLYEli Lilly and Company$0$35,153,609 â–¼-100.0%00.0%HealthcareMRNAModerna$0$10,160,000 â–¼-100.0%00.0%HealthcareTERNTerns Pharmaceuticals$0$5,525,056 â–¼-100.0%00.0%HealthcareASNDAscendis Pharma A/S$0$4,057,670 â–¼-100.0%00.0%HealthcareABBVAbbVie$0$3,153,605 â–¼-100.0%00.0%HealthcareSLNOSoleno Therapeutics$0$2,293,045 â–¼-100.0%00.0%HealthcareBBIOBridgeBio Pharma$0$1,514,904 â–¼-100.0%00.0%HealthcareAPOGEE THERAPEUTICS INC$0$495,425 â–¼-100.0%00.0%COMAVALO THERAPEUTICS INC$0$432,522 â–¼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
